Showing results (51-60 of 65) with videos related to
Sort By:
Pageof 7
The New England Journal of Medicine|June 5, 2026
Obinutuzumab or Tacrolimus in Primary Membranous NephropathyFernando C Fervenza, Fan Fan Hou, Chuan-Ming Hao, et al.Frontiers in Immunology|March 4, 2021
A Novel Inflammatory Dendritic Cell That Is Abundant and Contiguous to T Cells in the Kidneys of Patients With Lupus NephritisSamir V Parikh, Ana Malvar, John Shapiro, et al.The New England Journal of Medicine|September 16, 2020
Two-Year, Randomized, Controlled Trial of Belimumab in Lupus NephritisRichard Furie, Brad H Rovin, Frédéric Houssiau, et al.BMC Plant Biology|June 9, 2016
Association mapping for cold tolerance in two large maize inbred panelsPedro Revilla, Víctor Manuel Rodríguez, Amando Ordás, et al.Kidney International|July 5, 2022
Molecular profiling of kidney compartments from serial biopsies differentiate treatment responders from non-responders in lupus nephritisSamir V Parikh, Ana Malvar, Huijuan Song, et al.Kidney International Reports|February 20, 2026
Impact of CKD on Life Participation in Latin AmericaAndrea Matus Gonzalez, Anastasia Hughes, Soledad Molina, et al.The New England Journal of Medicine|February 10, 2025
Efficacy and Safety of Obinutuzumab in Active Lupus NephritisRichard A Furie, Brad H Rovin, Jay P Garg, et al.Biology|June 27, 2024
Genetic and Phenotypic Evaluation of European Maize Landraces as a Tool for Conservation and Valorization of AgrobiodiversityCarlotta Balconi, Agustin Galaretto, Rosa Ana Malvar, et al.Annals of the Rheumatic Diseases|October 17, 2025
EULAR recommendations for the management of systemic lupus erythematosus with kidney involvement: 2025 updateAntonis Fanouriakis, Myrto Kostopoulou, Hans-Joachim Anders, et al.Kidney International Reports|September 22, 2025
Systematic Review and Network Meta-Analysis of Initial Treatments for Lupus NephritisAriel Izcovich, Fernando Tortosa, Agustín Bengolea, et al.Pageof 7